SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TRTN, AMED, PRTK

NEW YORK, Aug. 9, 2023

Triton International Limited (NYSE: TRTN)'s sale to Brookfield Infrastructure Partners L.P. If you are a Triton shareholder, click here to learn more about your rights and options.

Amedisys, Inc. (NASDAQ: AMED)'s sale to Optum for $101.00 per share. If you are an Amedisys shareholder, click here to learn more about your rights and options.

Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK)'s sale to Gurnet Point Capital and Novo Holdings A/S. Under the terms of the agreement, Paratek shareholders will receive $2.15 per share in cash, plus a Contingent Value Right of $0.85 per share payable upon the achievement of $320 million in U.S. NUZYRA net sales in any calendar year ending on or prior to December 31, 2026. If you are a Paratek shareholder, click here to learn more about your rights and options.

Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.